NCT05737693View on ClinicalTrials.gov

Enhancing Week-long Psychological Treatment for PTSD With Ketamine

PHASE2RecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

August 1, 2030

Study Completion Date

August 1, 2031

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Ketamine

Week-long exposure therapy with ketamine infusion on day 2 and 4 of the psychotherapy

DRUG

Midazolam

Week-long exposure therapy with midazolam infusion on day 2 and 4 of the psychotherapy

Trial Locations (2)

06510

RECRUITING

Yale University School of Medicine, New Haven

Unknown

RECRUITING

Tel Aviv University, Tel Aviv

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER